Editor's Note: Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer.
Journal: Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Published:
Authors
Bradley Schiff, Andrea Mcmurphy, Samar Jasser, Maher Younes, Dao Doan, Orhan Yigitbasi, Seungwon Kim, Ge Zhou, Mahitosh Mandal, Benjamin Bekele, F Holsinger, Steven Sherman, Sai-ching Yeung, Adel El Naggar, Jeffrey Myers
Relevant Conditions